Investor
BIO International Convention
The world's largest biotechnology partnering event, bringing together global pharma, emerging biotech, research institutions, and early stage investors.
- When
- June, Early June
- Where
- RotatingView on Google Maps
- Format
- In person
- Organiser
- Biotechnology Innovation Organization
- Region
- Global
- Scale
- About 20,000 attendees
- Founded
- 1993
The Signal
This convention serves as the central hub for licensing deals, drug discovery collaborations, and investment in the life sciences. The heart of the event is its massive partnering platform where thousands of one on one meetings take place. For digital health and healthtech operators, it highlights the integration of computational tools in biopharma pipelines. It is a critical venue for therapeutic development deals.
What to expect
- High value pharmaceutical licensing and research deals
- Presentations of clinical trial phase data
- Policy debates on drug pricing and patents
- Announcements of new computational drug discovery partnerships
Who is in the room
Biotech executives, pharmaceutical licensing teams, academic researchers, venture capitalists, and intellectual property attorneys attend the event.
Background
The convention began in the early nineteen nineties to represent the growing biotechnology sector separate from traditional chemical pharma. It has expanded to encompass global delegations, advanced therapeutics, and digital biology.
Related events
Running this event, or spotted something out of date?